Search
  • Infinitum Health Team

Maitake Mushroom Turns Breast Cancer Genes Off


With technology, comes great power. Genetic analysis has opened many new frontiers for us in health and medicine, but interestingly, they are also confirming over 2000 years of traditional medicine.​

A unique mushroom, Grifola frondosa, also known as Maitake mushroom (舞茸), has been used for over 2000 years in China and Japan. It is also called "Hen of the Woods" as well as "Dancing Mushroom" in Japan as finding it equaled its weight in silver at the time. This is also one of our key extracts in our Infinimin® Immunity Multivitamin.

It is already known that the Maitake (D-Fraction) mushroom is involved in stimulating the immune system and activating certain cells that attack cancer, including macrophages, T-cells, and natural killer cells. According to the U.S. National Cancer Institute, polysaccharide complexes present in Maitake mushrooms appear to have significant anticancer activity.

However, the exact molecular mechanism of the Maitake antitumoral effect is still unclear. It has been shown that Maitake (D-Fraction) induces apoptosis (cell death) in breast cancer cells by activation of BCL2-antagonist/killer 1 (BAK1) gene expression. At the present work, we are identifying which genes are responsible for the suppression of the tumoral phenotype mechanism induced by Maitake (D-Fraction) in breast cancer cells.

Human breast cancer MCF-7 cells were treated with and without increased concentrations of Maitake D-Fraction (36, 91, 183, 367 μg/mL) for 24 h. Total RNA were isolated and cDNA microarrays were hybridized containing 25,000 human genes. Employing the cDNA microarray analysis, we found that Maitake D-Fraction modified the expression of 4068 genes (2420 were upmodulated and 1648 were downmodulated) in MCF-7 breast cancer cells in a dose-dependent manner during 24 h of treatment.

The present data shows that Maitake D-Fraction suppresses the breast tumoral phenotype through a putative molecular mechanism modifying the expression of certain genes (such as IGFBP-7, ITGA2, ICAM3, SOD2, CAV-1, Cul-3, NRF2, Cycline E,ST7, and SPARC) that are involved in apoptosis stimulation, inhibition of cell growth and proliferation, cell cycle arrest, blocking migration and metastasis of tumoral cells, and inducing multidrug sensitivity. Altogether, these results suggest that Maitake D-Fraction could be a potential new target for breast cancer chemoprevention and treatment.

References

1. Alonso, Eliana Noelia et al. “Genes Related to Suppression of Malignant Phenotype Induced by Maitake D-Fraction in Breast Cancer Cells.” Journal of Medicinal Food 16.7 (2013): 602–617. PMC. Web. 23 Oct. 2015.

2. Deng G., Lim H., Seidman A., Fornier M., D'Andrea G., Wesa K., Yeung, S., Cunningham-Rundles, S., Vickers, AJ, Cassileth, B. 2009. "A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol 135:1215-1221.

3. Patel, S., Goyal, A. 2012. "Recent developments in mushrooms as anti-cancer therapeutics: a review." 3 Biotech (2012) 2:1-15. DOI 10.1007/s13205-011-0036-2. Preuss, H., Echard, B., Bagchi, D., Perricone, N.V., Zhuang, C. 2007. "Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom." Mol Cell Biochem (2007) 306:105-113. DOI 10.1007/s11010-007-9559-6.

#maitake #breastcancerawareness #genetics

618 views
  • Facebook Social Icon
  • Pinterest Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon

Copyright  2020.  All rights reserved.  Infinitum Health, LLC.  *These statements have not been evaluated by the Food and Drug Administration (FDA) or Federal Trade Commission (FTC).  These products are not intended to diagnose, treat, cure or prevent any disease.  This web site (inclusive of blog articles, email marketing, labeling on products and any reference links) are not to be used as a substitute for medical advice, diagnosis or treatment of any health condition or problem. Users of this web site (inclusive of blog articles, email marketing, labeling on products and any reference links) should not rely on information provided for their own health problems.  Any questions regarding your own health should be addressed to your physician or other healthcare provider.  We provide the research and information and request customers to read through it thoroughly and educate themselves to aid in making an informed and safe decision to buy.   US Patents: 14-454548, 62006732, 89065289, 89078900